Invectys focuses on the development of innovative anti-cancer therapeutic approaches in immunotherapy. It is backed by French and international private investors…
Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. …
To help us orient our long-term decisions and strategy, we rely on an experienced and dependable board of seasoned industry professionnals, investors and health…
Invectys’ Board of Directors and Managers are accompanied by top strategic advisors, experienced in both biotech entrepreneurship and management: David Epstein,…
Invectys’ Scientific and Clinical Board is composed of globally recognized top specialists and key opinion leaders: Professor Maurizio Zanetti, M.D. A professor…
Invectys Inc. is led by a team of experienced industry professionals, combining vision, scientific knowledge and management skills. Praveen Tyle, Ph.D., President…
